60 Degrees Pharmaceuticals, Inc. Common Stock (SXTP)
Official siteHEALTHCARE • BIOTECHNOLOGY • NASDAQ
Market Cap: $1.74M
Last updated: Nov 17, 2026 at 4:24 PM ET
60 Degrees Pharmaceuticals, Inc. Common Stock (SXTP) Statistics
60 Degrees Pharmaceuticals, Inc. Common Stock (SXTP) has a market cap of $1.74M and an enterprise value of $1.43M. It kept -825.05% of revenue as net income over the last 12 months. Revenue fell 27.45% over the last 12 months from the 12 months before.
Total Valuation
Enterprise value is 17.63% below the market cap, as cash exceeds debt.
| Market Cap | $1.74M |
|---|---|
| Enterprise Value | $1.43M |
| Latest price (Nov 17, 2026) | $0.53 |
Key Dates
| Last Earnings Date | Nov 16, 2026 |
|---|---|
| Fiscal Year End | December |
Valuation Ratios
The price to sales ratio is 1.9x.
| P/S Ratio | 1.9x |
|---|---|
| Forward P/S | 1.7x |
Price Statistics
The stock is down 85.33% over 52 weeks and trades 42.39% below its 50-day average.
| Beta (1Y) | 1.59 |
|---|---|
| 52-Week Change | -85.33% |
| 1-Month Change | -35.44% |
| 3-Month Change | -52.73% |
| 6-Month Change | -62.12% |
| Total Return (1Y) | -85.33% |
| Total Return (3Y CAGR) | -85.26% |
| Max Drawdown (1Y) | -90.50% |
| Max Drawdown (3Y) | -99.83% |
| Sharpe Ratio (1Y) | -1.31 |
| Correlation with SPY (1Y) | 0.14 |
| 50-Day Average | $0.92 |
| 200-Day Average | $1.59 |
| 52-Week Range | $0.48 to $5.30 |
| RSI (14 Days) | 33.2 |
| Average Volume (20 Days) | 1.00M |
Financial Position
Current assets cover 1.17x current liabilities, and total debt is 0.00x shareholder equity.
| Current Ratio | 1.17x |
|---|---|
| Quick Ratio | 0.91x |
| Debt / Equity | 0.00x |
| Interest Coverage | -1143.56x |
Returns and Efficiency
Return on equity is -991.94% and return on assets is -269.94% over the last 12 months.
| Return on Equity (ROE) | -991.94% |
|---|---|
| Return on Assets (ROA) | -269.94% |
| Return on Capital Employed (ROCE) | -924.64% |
| Asset Turnover | 0.21x |
| Inventory Turnover | 0.95x |
| Receivables Turnover | 2.24x |
| Cash Conversion Cycle | -244 days |
Scores
SXTP has an Altman Z-Score of -32.74, in the distress zone below 1.81, and a Piotroski F-Score of 4 of 9, in the average band of 3 to 7.
Altman Z-ScoreDistress below 1.81Safe above 2.99
Piotroski F-ScoreWeak at 2 or lessStrong at 8 or more
| Altman Z-Score | -32.74 |
|---|---|
| Altman Z Zone | Distress |
| Piotroski F-Score | 4 of 9 |
| Piotroski Strength | Average |
Income Statement
Revenue was $1.01M over the last 12 months.
| Revenue | $1.01M |
|---|---|
| Revenue Growth (YoY) | -27.45% |
| Gross Profit | $621.97K |
| Operating Income | -$8.81M |
| Pretax Income | -$8.35M |
| Net Income | -$8.35M |
| EBITDA | -$8.09M |
| EBIT | -$8.35M |
| Reported EPS (TTM) | -$11.03 |
Trailing 12 months through Sep 30, 2026.
Balance Sheet
Shareholder equity funds 27.25% of the $3.09M in total assets.
| Cash and Equivalents | $306.19K |
|---|---|
| Total Debt | $0 |
| Net Cash | $306.19K |
| Net Cash Per Share | $0.09 |
| Working Capital | $372.87K |
| Shareholder Equity | $842.02K |
| Tangible Book Value | $537.99K |
| Total Assets | $3.09M |
| Total Liabilities | $2.34M |
Balance sheet as of Sep 30, 2026.
Cash Flow
| Operating Cash Flow | -$8.11M |
|---|---|
| FCF Per Share | -$2.34 |
| Depreciation and Amortization | $256.36K |
Trailing 12 months through Sep 30, 2026.
Margins
The operating margin is -870.39%.
| Gross Margin | 61.44% |
|---|---|
| Operating Margin | -870.39% |
| Pretax Margin | -825.23% |
| Net Margin | -825.05% |
| EBITDA Margin | -799.19% |
| EBIT Margin | -824.51% |
| Gross Margin (5Y Average) | -2.67% |
Growth
Revenue grew 40.21% a year over 3 years.
| Revenue Growth (3Y CAGR) | +40.21% |
|---|---|
| Revenue Growth (5Y CAGR) | -8.37% |
Dividends and Yields
SXTP does not pay a dividend.
| Buyback Yield | -240.69% |
|---|---|
| Shareholder Yield | -240.69% |
Stock Splits
The last split was a 1-for-4 reverse split on Jan 20, 2026.
| Last Split Date | Jan 20, 2026 |
|---|---|
| Split Type | Reverse split |
| Split Ratio | 1:4 |
Peer Position
Against 4 similar companies, SXTP has the 4th highest P/S.
P/S RatioPeer median 29.2x
Revenue Growth (Trailing 4 Quarters, YoY)Peer median -100.00%
| P/S Ratio | 1.9x vs 29.2x median |
|---|---|
| Revenue Growth (Trailing 4 Quarters, YoY) | -27.45% vs -100.00% median |
Analyst Forecast
Consensus estimates put revenue growth at 9.84% a year over the next 2 fiscal years.
| Revenue Growth Forecast (2Y CAGR) | +9.84% |
|---|
Price Target
Analyst price targets are part of paid GNG plans. See plans
Frequently Asked Questions About SXTP
What is SXTP's market cap?
60 Degrees Pharmaceuticals, Inc. Common Stock has a market cap of $1.74M. Its enterprise value, which adds debt and subtracts cash, is $1.43M.
How many shares of SXTP are outstanding?
60 Degrees Pharmaceuticals, Inc. Common Stock has 3.55M shares outstanding.
Does SXTP pay a dividend?
No. 60 Degrees Pharmaceuticals, Inc. Common Stock does not pay a dividend.
How much debt does SXTP have?
60 Degrees Pharmaceuticals, Inc. Common Stock has $0 of total debt and $306.19K of cash and equivalents, a net cash position of $306.19K.
SXTP pages: Overview, Charting, Earnings, Forecast, Financials, Statistics, Competitors